Cargando…
Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality
Background. In K. pneumoniae KPC (KPC-Kp) bloodstream infections (BSI), INCREMENT CPE score >7, Charlson Comorbidity Index (CCI) ≥3 and septic shock are recognized predictors of mortality, with a possible beneficial effect of combination therapy in seriously ill patients. Materials and Methods. W...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776375/ https://www.ncbi.nlm.nih.gov/pubmed/36552024 http://dx.doi.org/10.3390/biomedicines10123268 |
_version_ | 1784855850098098176 |
---|---|
author | Corcione, Silvia De Benedetto, Ilaria Shbaklo, Nour Ranzani, Fabio Mornese Pinna, Simone Castiglione, Anna Scabini, Silvia Bianco, Gabriele Cavallo, Rossana Mirabella, Stefano Romagnoli, Renato De Rosa, Francesco Giuseppe |
author_facet | Corcione, Silvia De Benedetto, Ilaria Shbaklo, Nour Ranzani, Fabio Mornese Pinna, Simone Castiglione, Anna Scabini, Silvia Bianco, Gabriele Cavallo, Rossana Mirabella, Stefano Romagnoli, Renato De Rosa, Francesco Giuseppe |
author_sort | Corcione, Silvia |
collection | PubMed |
description | Background. In K. pneumoniae KPC (KPC-Kp) bloodstream infections (BSI), INCREMENT CPE score >7, Charlson Comorbidity Index (CCI) ≥3 and septic shock are recognized predictors of mortality, with a possible beneficial effect of combination therapy in seriously ill patients. Materials and Methods. We conducted a ten-year retrospective study including all KPC-Kp BSI in patients ≥18 years of age with the aim to evaluate the characteristics and impact of appropriate empirical therapy, either monotherapy or combination therapy, and targeted therapy on mortality. Appropriate therapy was defined as at least one active antimicrobial agent with in vitro activity against KPC-kp demonstrated by susceptibility testing, administered within 48 h from blood culture collection. Results. The median age of the 435 analyzed patients was 66.09 years (IQR 54.87–73.98). The median CCI was 4. KPC-Kp colonization was present in 324 patients (74.48%). The probable origin of the KPC-Kp BSI was not identified in 136 patients (31.26%), whereas in 120 (27.59%) patients, it was CVC-related, and in 118 (27.13%), it was respiratory. Source control was achieved in 87 patients (72.5%) with CVC-related KPC-Kp BSI. The twenty-eight-day survival was 70.45% for empirical monotherapy, 63.88% for empirical combination therapy and 57.05% for targeted therapy (p = 0.0399). A probable source of KPC-Kp BSI other than urinary, CVC or abdominal [aHR 1.64 (IC 1.15–2.34) p = 0.006] and deferred targeted therapy [HR 1.67 (IC 1.12–2.51), p= 0.013] emerged as predictors of mortality, whereas source control [HR 0.62 (IC 0.44–0.86), p = 0.005] and ceftazidime/avibactam administration in empirical therapy [aHR 0.37 (IC 0.20–0.68) p = 0.002] appeared as protective factors. Discussion. These data underline the importance of source control together with timing appropriateness in the early start of empirical therapy over the choice of monotherapy or combination therapy and the use of ceftazidime/avibactam against KPC-Kp BSI. |
format | Online Article Text |
id | pubmed-9776375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97763752022-12-23 Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality Corcione, Silvia De Benedetto, Ilaria Shbaklo, Nour Ranzani, Fabio Mornese Pinna, Simone Castiglione, Anna Scabini, Silvia Bianco, Gabriele Cavallo, Rossana Mirabella, Stefano Romagnoli, Renato De Rosa, Francesco Giuseppe Biomedicines Article Background. In K. pneumoniae KPC (KPC-Kp) bloodstream infections (BSI), INCREMENT CPE score >7, Charlson Comorbidity Index (CCI) ≥3 and septic shock are recognized predictors of mortality, with a possible beneficial effect of combination therapy in seriously ill patients. Materials and Methods. We conducted a ten-year retrospective study including all KPC-Kp BSI in patients ≥18 years of age with the aim to evaluate the characteristics and impact of appropriate empirical therapy, either monotherapy or combination therapy, and targeted therapy on mortality. Appropriate therapy was defined as at least one active antimicrobial agent with in vitro activity against KPC-kp demonstrated by susceptibility testing, administered within 48 h from blood culture collection. Results. The median age of the 435 analyzed patients was 66.09 years (IQR 54.87–73.98). The median CCI was 4. KPC-Kp colonization was present in 324 patients (74.48%). The probable origin of the KPC-Kp BSI was not identified in 136 patients (31.26%), whereas in 120 (27.59%) patients, it was CVC-related, and in 118 (27.13%), it was respiratory. Source control was achieved in 87 patients (72.5%) with CVC-related KPC-Kp BSI. The twenty-eight-day survival was 70.45% for empirical monotherapy, 63.88% for empirical combination therapy and 57.05% for targeted therapy (p = 0.0399). A probable source of KPC-Kp BSI other than urinary, CVC or abdominal [aHR 1.64 (IC 1.15–2.34) p = 0.006] and deferred targeted therapy [HR 1.67 (IC 1.12–2.51), p= 0.013] emerged as predictors of mortality, whereas source control [HR 0.62 (IC 0.44–0.86), p = 0.005] and ceftazidime/avibactam administration in empirical therapy [aHR 0.37 (IC 0.20–0.68) p = 0.002] appeared as protective factors. Discussion. These data underline the importance of source control together with timing appropriateness in the early start of empirical therapy over the choice of monotherapy or combination therapy and the use of ceftazidime/avibactam against KPC-Kp BSI. MDPI 2022-12-16 /pmc/articles/PMC9776375/ /pubmed/36552024 http://dx.doi.org/10.3390/biomedicines10123268 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Corcione, Silvia De Benedetto, Ilaria Shbaklo, Nour Ranzani, Fabio Mornese Pinna, Simone Castiglione, Anna Scabini, Silvia Bianco, Gabriele Cavallo, Rossana Mirabella, Stefano Romagnoli, Renato De Rosa, Francesco Giuseppe Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality |
title | Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality |
title_full | Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality |
title_fullStr | Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality |
title_full_unstemmed | Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality |
title_short | Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality |
title_sort | ten years of kpc-kp bloodstream infections experience: impact of early appropriate empirical therapy on mortality |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776375/ https://www.ncbi.nlm.nih.gov/pubmed/36552024 http://dx.doi.org/10.3390/biomedicines10123268 |
work_keys_str_mv | AT corcionesilvia tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT debenedettoilaria tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT shbaklonour tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT ranzanifabio tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT mornesepinnasimone tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT castiglioneanna tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT scabinisilvia tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT biancogabriele tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT cavallorossana tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT mirabellastefano tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT romagnolirenato tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality AT derosafrancescogiuseppe tenyearsofkpckpbloodstreaminfectionsexperienceimpactofearlyappropriateempiricaltherapyonmortality |